Evidence map›Paper›PMID 32823650›Full record

ArticleAntibiotics (Basel, Switzerland)2020

Effective Treatment for Uncomplicated Urinary Tract Infections with Oral Fosfomycin, Single Center Four Year Retrospective Study.

Miroslav Fajfr, Michal Balik, Eva Cermakova, Pavel Bostik

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06017479 (Effectiveness of Single Dose Fosfomycin and Single Dose Levofloxacin as Pre-urodynamic Antibiotic Prophylaxis for Urinary Tract Infection Prevention in Post-Urodynamic Examination), which is not on this map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06017479 phase1 / phase2completednot on this mapstarted 2022, after this paper: background citation

Effectiveness of Single Dose Fosfomycin and Single Dose Levofloxacin as Pre-urodynamic Antibiotic Prophylaxis for Urinary Tract Infection Prevention in Post-Urodynamic Examination

TypeinterventionalSponsorIndonesia UniversityRan2022 to 2024Enrolled126ConditionsUrological System Complication of Procedure, Urinary Tract InfectionsArmsFosfomycin 3000 MG, Levofloxacin 500mg
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Therapeutic strategies for multi-resistantJAC-antimicrobial resistance · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Prevalence of bacteriuria in cats with neurogenic bladder.Veterinary research communications · 2022
    Article
  11. Article
  12. Virulence and antimicrobial resistance factors inFrontiers in veterinary science · 2022
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Miroslav FajfrInstitute of Clinical Microbiology, University Hospital, Sokolska 581, 500 05 Hradec Kralove, Czech Republic.ORCID 0000-0002-3561-9482
Michal BalikFaculty of Medicine in Hradec Kralove, Charles University in Prague, Simkova 870, 500 38 Hradec Kralove, Czech Republic.ORCID 0000-0003-2273-3099
Eva CermakovaFaculty of Medicine in Hradec Kralove, Department of Medical Biophysics, Charles University in Prague, Simkova 870, 500 38 Hradec Kralove, Czech Republic.
Pavel BostikInstitute of Clinical Microbiology, University Hospital, Sokolska 581, 500 05 Hradec Kralove, Czech Republic.ORCID 0000-0003-2691-6458
Charles University · CZ

Funding

Ministerstvo Obrany České Republiky Long term organization development planMinisterstvo Zdravotnictví Ceské Republiky UHHK, 00179906
6 · The paper itself

Abstract

Fosfomycin represents a relatively old antibiotic, but it is experiencing a comeback in recent years. According to some studies, the increasing therapeutic use of this drug led to a rapid increase in the levels of resistance in bacteria causing urinary tract infection. In the presented study, levels of resistance to fosfomycin in more than 3500 bacterial isolates before and after fosfomycin introduction into therapeutic use in the Czech Republic and the clinical efficacy of treatment in 300 patients using this drug were assessed. The results show that the resistance levels to fosfomycin in

Indexed as

fosfomycinresistanceurinary infection

Identifiers

PMID32823650
PMCPMC7459894
OpenAlexW3048839847

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.